
    
      There will be a screening visit about 4 weeks receiving study drug. Upon qualifying for the
      study after the screening visit, patients will then be asked to stop taking their current
      phosphate binder for about 2 weeks. Then, if patients continue to qualify for the study, they
      will be entered in the study that lasts about 28 days. Study visits will happen every week
      during the patient's usual dialysis appointments. There will be a total of up to 9 visits for
      this study, and total participation time could last up to 8 weeks.
    
  